Quick
Links

Past Charts

Home » Adjusted EBITDA May Look Nice but CFFO is the Real Story

- The chart shows the last three years and Last Twelve Months of Cash Flow From Operations (CFFO) for the six MSOs in the Viridian Capital Value Tracker database with market caps between $25M and $100M.

- Most companies showed positive adjusted EBITDA for 2021, but only half had positive CFFO.

- What is the difference? The difference primarily relates to two factors: taxes paid (expense minus changes in accruals), and changes in operating working capital (chiefly inventories and receivables).

- Investors should pay more attention to CFFO because it is a GAAP number invariant to company choices of depreciation methods, inventory accounting methods, and valuation reserves. It can’t be fudged and tells the real picture of a company’s cash-generating capability.

- The companies on the list fall into four groups:
  - C21 Investments (CXXI: CSE) and Vext Science (VEXT: CSE) were the only two companies to have a stable positive cash flow positive over the entire period in the graph.
  - Red White & Bloom (RWB: CSE) and Acreage (ACRDF: OTC) have been significantly negative cash flow over the entire period.
  - Cansortium (TIUM.USD: CSE) appears to be a generally improving cash flow company and is the most cash flow positive company during the most recent twelve months.
  - AYR Wellness (AYR.A: CSE) has shown the most significant downward trend in CFO over the period. Part of AYR’s issue is that working capital has been a large use of cash. We would expect this during a period of significant growth. AYR was positive before working capital changes in all periods except the last twelve months.

- The current environment stresses cannabis profitability and liquidity, forcing Investors to sharpen their credit analysis skills. Start by minimizing your use of adjusted EBITDA and concentrating on the fundamental cash flow metric, CFFO.